DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development von Binder, H, Willscher, E, Loeffler-Wirth, H, Hopp, L, Jones, D T W, Pfister, S M, Kreuz, M, Gramatzki, D, Fortenbacher, E, Hentschel, B, Tatagiba, M, Herrlinger, U, Vatter, H, Matschke, J, Westphal, M, Krex, D, Schackert, G, Tonn, J C, Schlegel, U, Steiger, H-J, Wick, W, Weber, R G, Weller, M, Loeffler, M

Volltext

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas von Juratli, T. A., Kirsch, M., Geiger, K., Klink, B., Leipnitz, E., Pinzer, T., Soucek, S., Schrok, E., Schackert, G., Krex, D.

Volltext

A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients von Schaich, M., Kestel, L., Pfirrmann, M., Robel, K., Illmer, T., Kramer, M., Dill, C., Ehninger, G., Schackert, G., Krex, D.

Volltext

A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network von Seidel, C., Hentschel, B., Simon, M., Schnell, O., Heese, O., Tatagiba, M., Krex, D., Reithmeier, T., Kowoll, A., Weller, M., Wick, W.

Volltext

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial von Weller, J., Schäfer, N., Schaub, C., Tzaridis, T., Zeyen, T., Schneider, M., Potthoff, A. L., Giordano, F. A., Steinbach, J. P., Zeiner, P. S., Kowalski, T., Sabel, M., Hau, P., Krex, D., Grauer, O., Goldbrunner, R., Schnell, O., Tabatabai, G., Ringel, F., Schmidt-Graf, F., Brehmer, S., Tonn, J. C., Bullinger, L., Vajkoczy, P., Glas, M., Vatter, H., Herrlinger, U., Seidel, C.

Volltext

Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers von DICKINSON, R. E, DALLOL, A, BIECHE, I, KREX, D, MORTON, D, MAHER, E. R, LATIF, F

Volltext

Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis von Hill, V K, Underhill-Day, N, Krex, D, Robel, K, Sangan, C B, Summersgill, H R, Morris, M, Gentle, D, Chalmers, A D, Maher, E R, Latif, F

Volltext

Rosette-forming glioneuronal tumor of the fourth ventricle in an elderly patient von Podlesek, D., Geiger, K., Hendry, D. J., Schackert, G., Krex, D.

Volltext

Complementary therapy use in patients with glioma: An observational study von HEESE, O, SCHMIDT, M, KREX, D, SCHACKERT, G, REITHMEIER, T, NIKKHAH, G, LÖFFLER, M, WELLER, M, WESTPHAL, M, NICKEL, S, BERGER, H, GOLDBRUNNER, R, TONN, J. C, BÄHR, O, STEINBACH, J. P, SIMON, M, SCHRAMM, J

Volltext

Genesis of cerebral aneurysms--an update von Krex, D, Schackert, H K, Schackert, G

Volltext

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial von Wick, Wolfgang, Prof, Platten, Michael, Prof, Meisner, Christoph, PhD, Felsberg, Jörg, MD, Tabatabai, Ghazaleh, MD, Simon, Matthias, MD, Nikkhah, Guido, Prof, Papsdorf, Kirsten, MD, Steinbach, Joachim P, Prof, Sabel, Michael, MD, Combs, Stephanie E, MD, Vesper, Jan, MD, Braun, Christian, MD, Meixensberger, Jürgen, Prof, Ketter, Ralf, MD, Mayer-Steinacker, Regine, MD, Reifenberger, Guido, Prof, Weller, Michael, Prof

Volltext

Long-term survival with glioblastoma multiforme von Krex, Dietmar, Klink, Barbara, Hartmann, Christian, von Deimling, Andreas, Pietsch, Torsten, Simon, Matthias, Sabel, Michael, Steinbach, Joachim P., Heese, Oliver, Reifenberger, Guido, Weller, Michael, Schackert, Gabriele

Volltext

P11.21.B Distinct age-related molecular and clinical features inIDH-Wildtype Glioblastoma von Richter, S, Stasik, S, Schackert, G, Thiede, C, Krex, D, Juratli, T A

Volltext

P11.21.B Distinct age-related molecular and clinical features in IDH -Wildtype Glioblastoma von Richter, S, Stasik, S, Schackert, G, Thiede, C, Krex, D, Juratli, T A

Volltext

Erratum to: The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas von Juratli, T. A., Kirsch, M., Geiger, K., Klink, B., Leipnitz, E., Pinzer, T., Soucek, S., Schrock, E., Schackert, G., Krex, D.

Volltext

Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms von KREX, Dietmar, RÖHL, Henning, KÖNIG, Inke R, ZIEGLER, Andreas, SCHACKERT, Hans K, SCHACKERT, Gabriele

Volltext

Lack of association between Endoglin intron 7 insertion polymorphism and intracranial aneurysms in a white population : Evidence of racial/ethnic differences von KREX, Dietmar, ZIEGLER, Andreas, SCHACKERT, Hans Konrad, SCHACKERT, Gabriele

Volltext

P14.64 PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma von Kebir, S, Pierscianek, D, Proescholdt, M, Hau, P, Grosu, A, Krex, D, Sure, U, Scheffler, B, Stuschke, M, Glas, M

Volltext

Matrix metalloproteinase-9 coding sequence single-nucleotide polymorphisms in caucasians with intracranial aneurysms von Krex, Dietmar, Kotteck, Kerstin, König, Inke R, Ziegler, Andreas, Schackert, Hans K, Schackert, Gabriele

Volltext

Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme von KRAUS, Jürgen A, GLESMANN, Nicole, BECK, Martina, KREX, Dietmar, KLOCKGETHER, Thomas, SCHACKERT, Gabriele, SCHLEGEL, Uwe

Volltext